Silk fibroin encapsulated powder reservoirs for sustained release of adenosine.
暂无分享,去创建一个
David L. Kaplan | Eleanor M. Pritchard | D. Kaplan | C. Szybala | Detlev Boison | Cory Szybala | D. Boison | D. Kaplan
[1] B. Lippold,et al. Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersion , 1989 .
[2] A. Daugherty,et al. Pharmacological modulation of the tissue response to implanted polylactic-co-glycolic acid microspheres , 1997 .
[3] D. Boison. Adenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies , 2009, Epilepsy Research.
[4] Kinam Park,et al. Mechanisms of controlled drug release from drug-eluting stents. , 2006, Advanced drug delivery reviews.
[5] D. Boison. The adenosine kinase hypothesis of epileptogenesis , 2008, Progress in Neurobiology.
[6] A. Dash,et al. Therapeutic applications of implantable drug delivery systems. , 1998, Journal of pharmacological and toxicological methods.
[7] A. Coombes,et al. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. , 1999, Vaccine.
[8] T. Higuchi. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.
[9] N. Peppas,et al. Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.
[10] Ung-Jin Kim,et al. Structure and properties of silk hydrogels. , 2004, Biomacromolecules.
[11] Mingzhong Li,et al. Enzymatic degradation behavior of porous silk fibroin sheets. , 2003, Biomaterials.
[12] G. Kidder. Adenosine kinase from , 1982 .
[13] G. Vunjak‐Novakovic,et al. Silk fibroin as an organic polymer for controlled drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[14] T. Asakura,et al. Solvent- and mechanical-treatment-induced conformational transition of silk fibroins studies by high-resolution solid-state carbon-13 NMR spectroscopy , 1990 .
[15] H. Rupprecht,et al. Film coating of pellets with insoluble polymers obtained in situ crosslinking in the fluidized bed , 1993 .
[16] D. Kaplan,et al. In vivo degradation of three-dimensional silk fibroin scaffolds. , 2008, Biomaterials.
[17] H. Brem,et al. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. , 2005, Anticancer research.
[18] T. Dunwiddie,et al. Adenosine and suppression of seizures. , 1999, Advances in neurology.
[19] I. Tucker,et al. Matrix formation in sustained release tablets: possible mechanism of dose dumping. , 2003, International journal of pharmaceutics.
[20] J. Siepmann,et al. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[21] A. Sollevi,et al. Experimental pain by ischaemic contractions compared with pain by intramuscular infusions of adenosine and hypertonic saline , 2003, European journal of pain.
[22] J. Siepmann,et al. Polymer blends for controlled release coatings. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[23] D. Kaplan,et al. Silk microspheres for encapsulation and controlled release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[24] T. Dahl,et al. Mechanisms to Control Drug Release from Pellets Coated with a Silicone Elastomer Aqueous Dispersion , 1992, Pharmaceutical Research.
[25] A Deutch,et al. Controlled release of dopamine from a polymeric brain implant: In vivo characterization , 1989, Annals of neurology.
[26] J. McPherson,et al. The human immune response to reconstituted bovine collagen. , 1986, Journal of immunology.
[27] Nicholas A. Peppas,et al. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .
[28] David L Kaplan,et al. In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth. , 2008, Biomaterials.
[29] N. Déglon,et al. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Fariña,et al. Potential applications of PLGA film-implants in modulating in vitro drugs release. , 2002, International journal of pharmaceutics.
[31] Christopher T. Rhodes,et al. The sustained release coating of solid dosage forms : a historical review , 1995 .
[32] Randall J Mrsny,et al. Formulation and delivery issues for monoclonal antibody therapeutics. , 2006, Advanced drug delivery reviews.
[33] Robert Langer,et al. INVITED REVIEW POLYMERIC DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE , 1980 .
[34] J. Swarbrick,et al. Encyclopedia of Pharmaceutical Technology , 2006 .
[35] K. Shakesheff,et al. Polymer carriers for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.
[36] S. Prasong,et al. In vitro Degradation Behavior of Bombyx mori Silk Fibroin Films Exposure to Protease XXIII , 2009 .
[37] Peng Xu,et al. Biomaterial coatings by stepwise deposition of silk fibroin. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[38] K. Shakesheff,et al. Polymeric systems for controlled drug release. , 1999, Chemical reviews.
[39] Jiyoung M Dang,et al. Natural polymers for gene delivery and tissue engineering. , 2006, Advanced drug delivery reviews.
[40] M. J. Lynch,et al. Dissolution and compatibility considerations for the use of mannitol in solid dosage forms. , 1969, Journal of pharmaceutical sciences.
[41] D. Boison. Adenosine-Based Cell Therapy Approaches for Pharmacoresistant Epilepsies , 2007, Neurodegenerative Diseases.
[42] David L Kaplan,et al. Silk polymer-based adenosine release: therapeutic potential for epilepsy. , 2008, Biomaterials.
[43] W. Mark Saltzman,et al. New Methods for Direct Delivery of Chemotherapy for Treating Brain Tumors , 2006, The Yale journal of biology and medicine.
[44] T. Vandamme,et al. Controlled release of levamisole from poly-(E-caprolactone) matrices: III. Effects of molecular weight and polymer coating on drug release , 1996 .
[45] N. de Tribolet,et al. Preoperative silk suture embolization of cerebral and dural arteriovenous malformations. , 2001, Neurosurgical focus.
[46] K. Fujimoto,et al. Rat brain expresses serum calcium-decreasing factor (caldecrin) , 2002, Neuroscience Letters.
[47] Eleanor M. Pritchard,et al. Antiepileptic effects of silk-polymer based adenosine release in kindled rats , 2009, Experimental Neurology.
[48] R. Simon,et al. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. , 2007, Brain : a journal of neurology.
[49] David L Kaplan,et al. In vitro degradation of silk fibroin. , 2005, Biomaterials.
[50] R. Bodmeier,et al. Dry polymer powder coating and comparison with conventional liquid-based coatings for Eudragit) RS, ethylcellulose and shellac. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[51] M B McCarthy,et al. Functionalized silk-based biomaterials for bone formation. , 2001, Journal of biomedical materials research.
[52] D. Kaplan,et al. Effect of hydration on silk film material properties. , 2010, Macromolecular bioscience.
[53] David L Kaplan,et al. The inflammatory responses to silk films in vitro and in vivo. , 2005, Biomaterials.
[54] David L Kaplan,et al. Silk-based biomaterials. , 2003, Biomaterials.
[55] D. Boison. Adenosine kinase, epilepsy and stroke: mechanisms and therapies. , 2006, Trends in pharmacological sciences.
[56] David L Kaplan,et al. Nanolayer biomaterial coatings of silk fibroin for controlled release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.